focus -WSS

focus

author：Wikipedia 2025-09-30 12:11:09 - browse：5

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Use wet bulb globe temperature, not heat index, to protect workers

WSS

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

How to improve immunocompromised access to mAb treatments

15 die by electrocution after transformer explodes in northern India

Dairy farmers resist CDC push for PPE against bird flu virus

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

hotspot

focus

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

DIEP, the 'gold standard' of breast reconstruction, is under threat

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

How one medical school became remarkably diverse

First recipient of genetically engineered pig kidney has died

As demand for Covid shots wanes, Moderna seeks its next success

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Moonlake's readout produced a cash windfall. Risks remain

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

entertainment

Elevance, private equity launch primary care company

Apple Watch's A

Flagship, Pfizer team up in deal worth up to $7 billion

FDA seeking to stop procedures at two unregulated stem cell clinics

Manchin plays down potential 3rd

More hospitals are billing patients as online messages surge

explore

explore

focus

hotspot